FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel Lynch, president and CEO, will provide an update of corporate activities at the Wedbush PacGrow Life Sciences Management Access Conference on Wednesday, August 15th at 10:20 a.m. Eastern Daylight Time. The presentation will be held in the Gamshoge room at the Le Parker Meridien located in New York, New York.
